Osteosarcoma is the most frequent malignant primary bone tumor characterized by a high potency to form lung metastases which is the main cause of death. Unfortunately, the conventional chemotherapy is not fully effective on osteosarcoma metastases. The progression of a primary tumor to metastasis requires multiple processes, which are neovascularization, proliferation, invasion, survival in the bloodstream, apoptosis resistance, arrest at a distant organ, and outgrowth in secondary sites. Consequently, recent studies have revealed new insights into the molecular mechanisms of metastasis development. The understanding of the mechanism of molecular alterations can provide the identification of novel therapeutic targets and/or prognostic ...
open10siThis work was supported by the Plan Nacional 2008–2011 (ISC III/FEDER (Miguel Servet Program...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma is the most common pediatric primary non-hematopoietic bone tumor. Survival of these y...
International audienceOsteosarcoma is the most frequent malignant primary bone tumor characterized b...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
Metastases of osteosarcomas are heterogeneous. They may grow simultaneously with the primary tumor, ...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment strategies ...
Osteosarcoma is the most common primary malignant tumour of bone. Currently, despite treatment with ...
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimo...
Osteosarcoma (OS) is the most common malignant primary bone tumor in children and adolescents and fe...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
AbstractOsteosarcoma (OS) is the most common primary bone tumour in the paediatric age group. Treatm...
Osteosarcoma is the most common primary cancer of the bone and third most common cancer in children ...
Owing to its frequent occurrence and severe clinical picture, bone metastasis is an important proble...
open10siThis work was supported by the Plan Nacional 2008–2011 (ISC III/FEDER (Miguel Servet Program...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma is the most common pediatric primary non-hematopoietic bone tumor. Survival of these y...
International audienceOsteosarcoma is the most frequent malignant primary bone tumor characterized b...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
Metastases of osteosarcomas are heterogeneous. They may grow simultaneously with the primary tumor, ...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment strategies ...
Osteosarcoma is the most common primary malignant tumour of bone. Currently, despite treatment with ...
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimo...
Osteosarcoma (OS) is the most common malignant primary bone tumor in children and adolescents and fe...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
AbstractOsteosarcoma (OS) is the most common primary bone tumour in the paediatric age group. Treatm...
Osteosarcoma is the most common primary cancer of the bone and third most common cancer in children ...
Owing to its frequent occurrence and severe clinical picture, bone metastasis is an important proble...
open10siThis work was supported by the Plan Nacional 2008–2011 (ISC III/FEDER (Miguel Servet Program...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma is the most common pediatric primary non-hematopoietic bone tumor. Survival of these y...